05.06.21

Surface Ophthalmics’ Chronic Dry Eye Study Reaches 50% Enrollment Milestone

Source: Surface Ophthalmics, Inc.

05.04.21

Oculis Announces Financing to Advance Topical Therapies for Posterior and Anterior Segments

Source: Oculis

04.29.21

Lumenis Receives FDA Approval for Its IPL Device to Manage Dry Eye Disease and Launches OptiLight

Source: Lumenis

04.29.21

Aerie Pharmaceuticals Completes Enrollment of its Phase 2b Trial of AR-15512 for the Treatment of Patients with Dry Eye Disease

Source: Aerie Pharmaceuticals

04.28.21

Alcon Launches Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops in the U.S.

Source: Alcon

04.28.21

Novaliq Announces More Than Half of Patients Enrolled in CyclASol Phase 3 Dry Eye Disease Trial ESSENCE-2

Source: Novaliq GmbH

04.27.21

SIFI Initiates Patient Enrollment in Phase 2 Trial Evaluating Pro-Ocular in Dry Eye Disease

Source: SIFI

04.20.21

Palatin Announces Two Presentations at the 2021 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Source: Palatin

04.15.21

ProtoKinetix Engages Multi-National Partner for Formulation of Topical Drug to Treat DED & Ocular Inflammation

Source: ProtoKinetix

04.13.21

Bausch + Lomb Announces Topline Results From The First Phase 3 Trial Of NOV03 In Dry Eye Disease Associated With MGD

Source: Bausch + Lomb

View more stories